This is a Phase 3, multi centre, open label, long term (up to 52 weeks) study of the safety and efficacy of esketamine administered by nasal spray in treatment resistant depression. Study participants will …
Public hospital, purpose built research unit, 1.5 trial coordinators, 2 psychiatrists and 1 GP. Research experience 3-10 years 1 hospital pharmacist trained for clinical trials. Area of expertise psychiatry especially …
Feasibilities for all new studies are facilitated by a central point of contact, which is the Clinical Research Manager (Richard Verrelli) based in the Office for Research at The Royal …